Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting

PURPOSE: Imatinib inhibits platelet-derived growth factor receptor (PDGFR), and evidence shows that PDGFR participates in the development and progression of cervical cancer. Although imatinib has exhibited preclinical activity against cervical cancer, only minimal clinical therapeutic efficacy was o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Peng, Zhang, Wendian, Yang, Tan, Lu, Yao, Lu, Miao, Gai, Yongkang, Ma, Xiang, Xiang, Guangya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019625/
https://www.ncbi.nlm.nih.gov/pubmed/24855354
http://dx.doi.org/10.2147/IJN.S60178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019625/
https://www.ncbi.nlm.nih.gov/pubmed/24855354
http://dx.doi.org/10.2147/IJN.S60178

Ejemplares similares